32 Trending Stocks

Thu, Dec 3, 2020

Penumbra Inc

PEN 206.25
1.01 (0.5%)

Open: 202.51 High: 208.86 Low: 190.16

9 x 206.25 = 1856.25
x $206.25 =

NYSE: PEN $7 Billion Mid-Cap. Health Care Sector. Medical Equipment & Devices Industry. 5 Year Return 333%. 1 Year Return 22%. 2020 YTD Return 26%. Since Earnings 14%.

ST

External Links

Free Channels & more...

For Starters

Charts

image
image

52WL $121.80

The 52 Week Low is $121.80 set on Mon, Mar 23, 2020.

52WH $273.94

The 52 Week High is $273.94 set on Thu, Nov 12, 2020.

ATH $1,700.00

The All-Time High is $1,700.00 set on Thu, Sep 24, 2015.

52 Week Range

$121.80
$273.94
Mar 23, 2020
Nov 12, 2020

Earnings

-0.34

Earnings Per Share

792.72

Price To Earnings Ratio


Q2 Earnings for Apr, May & Jun

Mon, Aug 3, 2020

Since Q2 Earnings Report

PEN 7.1%


Q3 Earnings for Jul, Aug & Sep

Wed, Oct 28, 2020

Since Q3 Earnings Report

PEN 13.6%

Dividends

0.00

Dividend Yield

0.00

Dividend Rate

--

Ex-Dividend Date

--

Dividend Payment Date

--

Dividend Frequency

0

Dividend History

Profile

Penumbra Inc trades on the NYSE. PEN's market cap is 7.5 Billion.

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for the neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.

Website

Related Channels

Account Channels

Track your portfolio and more.